Although numerous parts of the world have shown to be potential sites where Rickettsia conorrii can be contracted (India, Pakistan, Israel, Ukraine, Russia, Kenya, Morocco, South Africa and countries of Northern Europe), Boutonneuse fever is most frequently diagnosed in the Mediterranean basin, which is why the terms "Mediterranean spotted fever" or "Marseilles fever" are frequently used [1] [2]. Boutonneuse fever is a zoonotic disease that develops after a tick bite, specifically by Rhipicephalus sanguineus, the common dog tick [3]. The infection is usually diagnosed in the warmer months (July-September) [1] [3], and the clinical presentation is similar to other rickettsioses - fever, a maculopapular rash and the presence of an eschar (known as "tache noir") at the site of the tick bite [3]. Only one eschar is found in virtually all infected individuals, but their absence or even the appearance of more than one eschar has been documented [1]. Moreover, patients will often not remember being bitten by a tick as the transmission of bacteria by ticks may occur while the ticks are in the stages of larvae or nymph, which are rarely noticed [2]. Myalgias, dyspnea, cough, and hepatosplenomegaly are less common symptoms [2]. The course of the disease is generally self-limiting, especially in children, and the rash, as well as fever, resolves spontaneously in the majority of individuals, but a more severe form of the disease is encountered in approximately 6% of cases [3] [4]. Dehydration, tachycardia, obtundation, stupor and electrolyte imbalance are hallmarks of severe infection that may eventually lead to thrombocytopenia, myocarditis, gastric bleeding, renal failure and multiple organ damage [5] [5]. Additionally, central nervous system infection (meningitis or encephalitis), although rare, is an important cause of mortality in patients suffering from this form of Boutonneuse fever [4] [5]. Several risk factors for clinical deterioration have been described, including diabetes mellitus, preexisting cardiac or renal insufficiency, glucose-6-phosphate dehydrogenase deficiency (G6PD), and alcoholism [2] [3]. Overall mortality rates are around 2.5% [2].

The diagnosis of Boutonneuse fever relies on three main factors - a thorough patient history, a detailed physical examination and microbiological investigation. Firstly, patients must be asked about their recent travel (or whether they are residents of the Mediterranean), as well as recent tick bites. A meticulous physical examination should follow, which may identify the site of the tick bite by detecting the typical eschar. More importantly, if signs and symptoms suggestive of more severe infection (hepatosplenomegaly, jaundice, petechial rash, meningismus) are detected during the exam, electrolyte and liver transaminase levels need to be assessed, as hyponatremia and increased aspartate aminotransferase or AST, can be seen, respectively [2]. Because of the risk for coagulopathy and thrombocytopenia, a complete blood count (CBC) and a full coagulation panel should also be drawn during workup. Although clinical criteria supported by data from patient history may be sufficient to make the diagnosis, the confirmation of Rickettsia conorrii and Boutonneuse fever as the underlying cause of symptoms can be made after isolating the bacteria by some of the recommended microbiological techniques. Cultivation using the shell vial system, indirect immunofluorescence, and polymerase chain reaction (PCR) seem to be most efficient, but PCR and immunofluorescence are favored due to their faster turnaround time, and they are performed whenever possible [2] [4] [5].

The primary treatment for Boutonneuse Fever is antibiotics, with doxycycline being the most commonly prescribed. Treatment is most effective when started early in the course of the disease. In cases where doxycycline is contraindicated, such as in pregnant women or young children, alternative antibiotics like azithromycin may be used.

With prompt and appropriate treatment, the prognosis for Boutonneuse Fever is generally good. Most patients recover fully within a few weeks. However, if left untreated, the disease can lead to complications such as severe organ damage or even death, particularly in older adults or those with weakened immune systems.

Boutonneuse Fever is caused by the bacterium Rickettsia conorii, which is transmitted to humans through the bite of infected ticks. The brown dog tick, Rhipicephalus sanguineus, is the primary vector. The bacteria live in the tick's salivary glands and are passed to humans during a blood meal.

Boutonneuse Fever is most commonly found in Mediterranean countries, including Italy, Spain, and Portugal, but cases have also been reported in Africa, the Middle East, and parts of Asia. The disease is more prevalent during the warmer months when ticks are most active. People who spend time outdoors in tick-infested areas are at higher risk.

Once transmitted to humans, Rickettsia conorii invades the endothelial cells lining blood vessels, causing inflammation and damage. This leads to the characteristic symptoms of fever, rash, and eschar. The bacteria can spread throughout the body, potentially affecting multiple organs if not treated promptly.

Preventing Boutonneuse Fever involves reducing exposure to ticks. This can be achieved by wearing protective clothing, using insect repellent, and performing regular tick checks after spending time outdoors. Keeping pets free of ticks and maintaining a clean environment can also help reduce the risk of infection.

Boutonneuse Fever is an infectious disease caused by Rickettsia conorii and transmitted by ticks. It presents with fever, rash, and an eschar at the tick bite site. Early diagnosis and treatment with antibiotics like doxycycline are crucial for a good prognosis. Preventive measures focus on minimizing tick exposure.

If you suspect you have Boutonneuse Fever, it's important to seek medical attention promptly. Symptoms include fever, headache, muscle aches, and a rash, often accompanied by a black spot at the site of a tick bite. Treatment with antibiotics is effective, especially when started early. To prevent infection, take precautions to avoid tick bites, such as wearing long sleeves and using insect repellent when in tick-prone areas.

1. Rovery C, Brouqui P, Raoult D. Questions on Mediterranean Spotted Fever a Century after Its Discovery. Emerging Infectious Diseases. 2008;14(9):1360-1367.
2. Mandell GL, Bennett JE, Dolin R. Mandel, Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, Pennsylvania: Churchill Livingstone; 2015.
3. Cascio A, Iaria C. Epidemiology and clinical features of Mediterranean spotted fever in Italy. Parassitologia. 2006;48(1-2):131-133.
4. Colomba C, Saporito L, Polara VF, Rubino R, Titone L. Mediterranean spotted fever: clinical and laboratory characteristics of 415 Sicilian children. BMC Infect Dis. 2006;6:60.
5. Aliaga L, Sánchez-Blázquez P, Rodríguez-Granger J, Sampedro A, Orozco M, Pastor J. Mediterranean spotted fever with encephalitis. J Med Microbiol. 2009;58(4):521-525.